While the torsinA/LAP1 complex is required for VLDL secretion, it should be noted that the hepatic steatosis and NASH resulting from torsinA/LAP1 deletion from hepatocytes is much more severe than that observed in other mice with decreased VLDL secretion. Here, TOR1AIP1 is linked to metabolic dysfunction-associated steatohepatitis.